United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68180-973_94052e3d-58b2-4f4b-8223-a47281c1a592
- Product NDC
- 68180-973
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- Lupin Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190320
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — .15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68180-973-01) · 68180-973-01
- 1000 TABLET in 1 BOTTLE (68180-973-03) · 68180-973-03
- 90 TABLET in 1 BOTTLE (68180-973-09) · 68180-973-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →